Internal Medicine, Medical Oncology · Charlotte, NC
NPI
1619189529
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
1021 Morehead Medical Dr, Ste A
Charlotte, NC, 28204
Phone (980) 442-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
461 services
Medicare patients, 2024
84
Average age 64
Drug cost, 2024
$1.5M
746 prescriptions
Company payments, 2025
$10K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley L Sumrall was code 99215 (office e&m - established), 201 times for 56 patients. In total Ashley L Sumrall billed 461 services in 12 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 201 | 56 | $99.55 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 172 | 57 | $11.79 | $2,028 |
| 99214 Office E&M - Established | Facility | 30 | 25 | $70.16 | $2,105 |
| 99205 Office E&M - New | Facility | 17 | 17 | $132.21 | $2,248 |
By year: 2022 $46K for 776 services; 2023 $27K for 287 services; 2024 $28K for 461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashley L Sumrall prescribed most often to Medicare patients was Dexamethasone, with 76 prescriptions and refills. In total Ashley L Sumrall wrote 746 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 76 | 89 | 36 | $1,433 |
| Levetiracetam Generic | 65 | 134 | 25 | $1,599 |
| Ondansetron Hcl Generic | 62 | 63 | 27 | $477 |
| Welireg Belzutifan | 42 | 42 | Under 11 | $911K |
| Eliquis Apixaban | 24 | 45 | Under 11 | $22K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | Under 11 | $418 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $307 |
| Tizanidine Hcl Generic | 19 | 19 | Under 11 | $137 |
| Sertraline Hcl Generic | 17 | 43 | Under 11 | $124 |
| Lamotrigine Generic | 17 | 49 | Under 11 | $289 |
| Clonazepam Generic | 15 | 15 | Under 11 | $138 |
| Furosemide Generic | 14 | 16 | Under 11 | $34.87 |
| Anastrozole Generic | 14 | 42 | Under 11 | $115 |
| Imatinib Mesylate Generic | 14 | 14 | Under 11 | $1,014 |
| Prochlorperazine Maleate Generic | 13 | 13 | Under 11 | $126 |
Brand drugs: - claims; generic drugs: 618 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley L Sumrall $10K ($10K in general payments such as food, travel and fees) from 4 companies. The largest payer was Jazz Pharmaceuticals Inc. with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.